Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Abbie Celniker
Biotech
Third Rock leads $82M series A for startup Flare Therapeutics
With $82M in financing, Third Rock Ventures launches Flare Therapeutics, which has developed a unique approach to targeting transcription factors.
Kevin Dunleavy
May 13, 2021 7:00am
New CEO, major Roche pact: Now, Rheos nabs new CSO
Oct 22, 2020 8:23am
After $700M-plus Merck buyout, Tilos CEO Fox lands at Rheos
Oct 21, 2019 9:45am
Third Rock puts $60M behind immunometabolism player Rheos
Mar 22, 2018 9:25am
